Marco H. Siderius
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
CXCR4-EGFR heteromers show ligand-dependent changes in conformation and signaling.
Journal: Cell chemical biology
Published: November 14, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasms.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 11, 2025
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: Nature communications
Published: November 04, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.
Journal: Biochemical pharmacology
Published: April 10, 2024
G protein-coupled receptors: a gateway to targeting oncogenic EVs?
Journal: Extracellular vesicles and circulating nucleic acids
Published: February 09, 2024
Discovery of 5-Phenylpyrazolopyrimidinone Analogs as Potent Antitrypanosomal Agents with In Vivo Efficacy.
Journal: Journal of medicinal chemistry
Published: July 20, 2023
Monitoring Snake Venom-Induced Extracellular Matrix Degradation and Identifying Proteolytically Active Venom Toxins Using Fluorescently Labeled Substrates.
Journal: Biology
Published: April 04, 2023
Exosomal release of the virus-encoded chemokine receptor US28 contributes to chemokine scavenging.
Journal: iScience
Published: March 04, 2023
To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?
Journal: International journal of molecular sciences
Published: February 07, 2023
Last Updated: 09/26/2026